Literature DB >> 15890951

Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus.

Taeg S Kim1, Stanley Perlman.   

Abstract

Mouse hepatitis virus strain JHM causes a chronic demyelinating disease in susceptible strains of rodents. Demyelination does not develop in infected RAG1-/- (recombination activation gene-deficient) mice but can be induced by several experimental interventions, including adoptive transfer of virus-specific T cells or antibodies. A common feature of demyelination in these models is extensive infiltration of macrophages/microglia into the white matter. The data obtained thus far do not indicate whether macrophage/microglia infiltration, in the absence of T cells or antibody, is sufficient to mediate demyelination. To determine whether the expression of a single macrophage chemoattractant, in the context of virus infection, could initiate the demyelinating process, we engineered a recombinant coronavirus that expressed the chemokine CCL2/monocyte chemoattractant protein-1. CCL2 has been implicated in macrophage infiltration into the central nervous system and is involved in demyelination in many experimental models of demyelination. Extensive macrophage/microglia infiltration and demyelination has developed in RAG1-/- mice infected with this recombinant virus. Thus, these results suggest that the minimal requirement for demyelination is increased expression of a single macrophage-attracting chemokine in the context of an inflammatory milieu, such as that induced by a viral infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890951      PMCID: PMC1112157          DOI: 10.1128/JVI.79.11.7113-7120.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha.

Authors:  Stephen C Robinson; Kate A Scott; Frances R Balkwill
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

3.  Expression and regulation of chemokine receptors in human natural killer cells.

Authors:  M Inngjerdingen; B Damaj; A A Maghazachi
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

4.  Cutting edge: CD8 T cell-mediated demyelination is IFN-gamma dependent in mice infected with a neurotropic coronavirus.

Authors:  Lecia Pewe; Stanley Perlman
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

5.  Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system.

Authors:  M T Liu; D Armstrong; T A Hamilton; T E Lane
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

6.  Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS.

Authors:  E Ontiveros; L Kuo; P S Masters; S Perlman
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

7.  Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus.

Authors:  B P Chen; W A Kuziel; T E Lane
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

8.  The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease.

Authors:  M T Liu; B P Chen; P Oertel; M J Buchmeier; D Armstrong; T A Hamilton; T E Lane
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

9.  Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.

Authors:  N G Gourmala; M Buttini; S Limonta; A Sauter; H W Boddeke
Journal:  J Neuroimmunol       Date:  1997-04       Impact factor: 3.478

Review 10.  Viral induced demyelination.

Authors:  S A Stohlman; D R Hinton
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

View more
  27 in total

1.  CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus.

Authors:  Stephen A Stohlman; David R Hinton; Beatriz Parra; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 2.  Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain".

Authors:  Edith V Sullivan; Natalie M Zahr
Journal:  Exp Neurol       Date:  2008-07-14       Impact factor: 5.330

3.  Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.

Authors:  Ajai A Dandekar; Katherine O'Malley; Stanley Perlman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus.

Authors:  Kathryn Trandem; Daniela Anghelina; Jingxian Zhao; Stanley Perlman
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 5.  Axonal pathology and demyelination in viral models of multiple sclerosis.

Authors:  Jane E Libbey; Thomas E Lane; Robert S Fujinami
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

6.  De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system.

Authors:  Jingxian Zhao; Jincun Zhao; Stanley Perlman
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

7.  Looking ahead: The risk of neurologic complications due to COVID-19.

Authors:  Carlos A Pérez
Journal:  Neurol Clin Pract       Date:  2020-08

8.  Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection.

Authors:  Leah P Shriver; Kristopher J Koudelka; Marianne Manchester
Journal:  J Neuroimmunol       Date:  2009-04-25       Impact factor: 3.478

Review 9.  Translational studies of alcoholism: bridging the gap.

Authors:  Natalie M Zahr; Edith V Sullivan
Journal:  Alcohol Res Health       Date:  2008

Review 10.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.